Safety, Tolerability, Pharmacokinetics, and Food Effect of BLU-782 in Healthy Adults

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The main objectives of this study are to assess the safety, tolerability, pharmacokinetics (PK), and food effect of BLU-782 in healthy adult subjects.

Key facts

Study ID

NCT03858075

Run by

Blueprint Medicines Corporation

People needed

108

Starts

2019-02-12

Expected to finish

2019-09-11

Last updated by the study team

2019-11-08

Who can join

Age: 19 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Medically healthy
• Non-smoker
• Body mass index (BMI) ≥ 18 and ≤ 32 kg/m2
• No clinically significant cardiac history
• No current electrocardiogram (ECG) abnormality
• Female must not be of childbearing potential

You may not qualify if…

• History of or current mental or legal incapacitation or major emotional problems
• History or current clinically significant medical/psychiatric condition/disease
• History of any illness that, in the opinion of the Investigator, might impact the results of the study or pose an additional risk to the participant
• History or current alcoholism/drug abuse
• History or current allergy to the study drug or a similar drug

Where it is running

• Undisclosed — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.